Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Public ClinicalTrials.gov record NCT01337089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Non-comparative, Open-label Extension Study to Assess the Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a six-month open-label extension (OLE) study to evaluate the safety of long-term nabiximols (Sativex®) therapy when used as an adjunctive treatment in participants with advanced cancer. The study provided continued availability of nabiximols to participants who completed a preceding Phase 3 study and new (de novo) participants.
Study identification
- NCT ID
- NCT01337089
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 660 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2011 (Actual)
- Primary completion
- Jan 27, 2016 (Actual)
- Completion
- Jan 27, 2016 (Actual)
- Last update posted
- Apr 12, 2023
2011 – 2016
United States locations
- U.S. sites
- 37
- U.S. states
- 18
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85018 | — |
| Not listed | Phoenix | Arizona | 85028 | — |
| Not listed | El Cajon | California | 92020 | — |
| Not listed | Gilroy | California | 95020 | — |
| Not listed | Glendale | California | 91204 | — |
| Not listed | Santa Rosa | California | 95403 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | Daytona Beach | Florida | 32117 | — |
| Not listed | Holiday | Florida | 34691 | — |
| Not listed | Jacksonville | Florida | 32257 | — |
| Not listed | Lynn Haven | Florida | 32444 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Stuart | Florida | 34994 | — |
| Not listed | Tampa | Florida | 33609 | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Newnan | Georgia | 30265 | — |
| Not listed | Stockbridge | Georgia | 30281 | — |
| Not listed | Woodlawn | Illinois | 62898 | — |
| Not listed | Ashland | Kentucky | 41101 | — |
| Not listed | Bossier City | Louisiana | 71111 | — |
| Not listed | Shreveport | Louisiana | 71105 | — |
| Not listed | Saint Louis Park | Minnesota | 55426 | — |
| Not listed | Kansas City | Missouri | 64132 | — |
| Not listed | Missoula | Montana | 59802 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | New York | New York | 10010 | — |
| Not listed | Flat Rock | North Carolina | 28731 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Cleveland | Ohio | 44119 | — |
| Not listed | Philadelphia | Pennsylvania | 19146 | — |
| Not listed | Houston | Texas | 77089 | — |
| Not listed | Laredo | Texas | 78041 | — |
| Not listed | Salt Lake City | Utah | 84112 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | Lacey | Washington | 98503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01337089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2023 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01337089 live on ClinicalTrials.gov.